Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New pill shows promise for slowing early uterine cancer

NCT ID NCT05634499

First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 22 times

Summary

This study tests a drug called giredestrant in 30 people with Grade 1 endometrial cancer. The goal is to see if the drug can shrink or control the cancer over 6 months without surgery. Participants take the drug daily and have regular biopsies to check progress.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Englewood Health/Hematology Oncology Practice of Englewood (HOPE)

    Englewood, New Jersey, 07631, United States

  • Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori IRST - PPDS

    Meldola, Emilia-Romagna, 47014, Italy

  • Jewish General Hospital

    Montreal, Quebec, H3T 1E2, Canada

  • McGill University Health Centre - Glen Site

    Montreal, Quebec, H4A 3J1, Canada

  • Minnesota Oncology Minneapolis

    Minneapolis, Minnesota, 55404, United States

  • Mount Sinai Medical Center

    Miami Beach, Florida, 33140, United States

  • Narodowy Inst.Onkol.im.Sklodowskiej-Curie Panstw.Inst.Bad Gliwice

    Gliwice, 44-101, Poland

  • Swietokrzyskie Centrum Onkologii

    Kielce, 25-734, Poland

  • Texas Oncology, P.A. - Fort Worth

    Fort Worth, Texas, 76104, United States

  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas, 72205, United States

  • Virginia Oncology Associates

    Norfolk, Virginia, 23502, United States

  • Western Pennsylvania Hospital

    Pittsburgh, Pennsylvania, 15224, United States

Conditions

Explore the condition pages connected to this study.